The PPI results showed that the target genes of IL6, IL10, TNF, IL1B, CXCL8, IL1A, CCL2, CSF2, CSF3, and CCL5 might be the core targets of OA-enhanced aspirin therapy for CRC. Here, CCL2 is linked to colorectal carcinoma.